Best Hyperthermic Intraperitoneal Chemotherapy (HIPEC) doctors: TOP 50 doctors

Assoc. Prof. Kıvanç Derya Peker has extensive experience in the medical field, specializing in Pancreatic Surgery, Gallbladder and Tracts Surgery, Liver Diseases Surgery, Stomach Diseases and Stomach Cancer Surgery, Obesity – Metabolic Surgery and Endoscopic Treatments, and Kidney Transplant. He has also done research into aging and stem cell treatments.

Prof. Deraco has dedicated his career to helping patients with complex cancers, particularly those affecting the peritoneum, a membrane in the abdomen. He began his medical career in 1989 at the Surgery and Experimental Oncology Departments of the Fondazione IRCCS, National Cancer Institute in Milan, Italy. Over the years, he has played a key role in advancing treatments for peritoneal surface malignancies (PSM). For more than a decade, he was the lead physician for the Peritoneal Surface Malignancies Program. Since 2017, he has served as the director of the Peritoneal Surface Malignancies Unit, where he continues to focus on providing cutting-edge care for his patients.

Prof. Deraco’s expertise is in specialized cancer treatments like Cytoreductive Surgery (CRS), Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC), and Pressurized Intra-Peritoneal Aerosolized Chemotherapy (PIPAC). These techniques aim to remove cancer and deliver heated chemotherapy directly to the abdomen, giving patients with PSM new hope. He has successfully treated over 1,200 patients using these advanced methods.

In addition to his clinical work, Prof. Deraco is a professor at Milan University, where he teaches future surgeons about peritoneal surface malignancies. His teaching extends internationally, as he has mentored over 30 postdoctoral fellows from prestigious institutions worldwide.

Prof. Deraco’s educational background is extensive. He earned his medical degree from the University of Messina in 1987 with top honors, followed by a specialization in general surgery five years later. His training continued in Paris, where he specialized in oncology at the prestigious Paris Dauphine University. He further honed his skills through fellowships in world-renowned institutions such as the Gustave Roussy Institute in France, the Royal Marsden Hospital in the UK, and the Washington Cancer Institute in the USA.

Throughout his career, Prof. Deraco has remained actively involved in research and professional organizations. He has published over 250 scientific articles and 25 book chapters, contributing to the advancement of cancer treatment globally. He serves on the board of multiple scientific societies dedicated to cancer research, including the Peritoneal Surface Oncology International Group (PSOGI) and the Italian Society for Loco-Regional Cancer Therapy (SITILO).

• Dr. Mustafa Solak specializes in Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
• Performs HIPEC using latest methods: heated chemotherapy, precision drug delivery, and cytoreductive surgery.
• International training at The University of Texas MD Anderson Cancer Center in the U.S.
• Board-certified oncologist with fellowship from Hacettepe University Cancer Institute.
• Member of renowned oncology societies, ensuring updated HIPEC techniques.
• Offers online consultations for global HIPEC patients.
• Fluent in English and Turkish for diverse patient communication.

• Dr. Abdulcabbar Kartal specializes in HIPEC for abdominal cancers.
• Uses innovative HIPEC methods: cytoreductive surgery, closed abdomen technique, early postoperative intraperitoneal chemotherapy.
• Trained internationally; holds a HIPEC course certificate from 2017.
• Member of Turkish Association of Endoscopic Laparoscopic Surgery.
• Certified by Turkish Surgical Association in 2014.
• Provides online consultations for HIPEC inquiries.
• Fluent in Turkish and proficient in English.

• Dr. Lana Bijelic specializes in HIPEC, treating peritoneal carcinomatosis.
• Performs HIPEC with advanced techniques: CRS, bidirectional chemotherapy, real-time monitoring.
• International HIPEC training in the USA, Spain, and Croatia.
• Certified by the American Board of Surgery, expertise in surgical oncology.
• Member of Society of Surgical Oncology, American College of Surgeons.
• Offers remote consultations for global HIPEC patients.
• Speaks English, Spanish, and Croatian fluently.

Dr. Ofer Merimsly is the best sarcoma, lymphoma, and lung cancer doctor within Israel and in the world. Also specializes in Whipple surgery treatment for patients with pancreatic cancer. Head of the National Center for sarcomas of bone and soft tissues of the Tel Aviv Medical Center Sourasky (Ichilov).

Specialty:

• Treatment of all types of lung cancer and thoracic organs
• Treatment of all types of sarcomas of bone and soft tissue
• Treatment stromal tumors of the gastrointestinal tract

Education and specialization:

• Higher medical education, graduated the Medical Faculty of the Hebrew University of Jerusalem, Israel
• Residency in General Oncology and Radiotherapy
• Training in the field of radiotherapy and brachytherapy at New York Hospital, USA
• Special refresher course for the treatment of tumors of the skeleton and soft tissues, Paris. France

Membership:

• President of the Society of oncologists and radiotherapists Israel
• The American Scientific Cancer Society
• European scientific medical organization
• European Society of Oncology of the musculoskeletal system
• International Society for the treatment of tumors of the connective tissue

Education and Career

2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career

Medicine Department of Internal Medicine

2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital

2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology

2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital

2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology

Memberships in Scientific Organizations

ASCO

ESMO

TTOD 

AVOD 

Publications

In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.

Awards Received

EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award

"The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"

Speeches Delivered at National Congresses, Conferences, and Symposia:

Courses, Meetings, and Certificates

ESMO certified Medical Oncologist since 2019

Dr. Auala Hubert is a board-certified Medical Oncologist & Radiotherapist with 33 years of experience, speaking both English and Hebrew. She is a member of several medical and social service committees and holds qualifications in Oncology and Radiotherapy.

• Dr. Domenico Sabia specializes in HIPEC, a targeted chemotherapy treatment.
• Performs HIPEC using innovative techniques: cytoreductive surgery, PIPAC.
• International training in Spain and Italy, enhancing HIPEC expertise.
• Accredited in advanced laparoscopic and robotic surgical methods.
• Member of GECOP and PSOGI, focusing on peritoneal malignancies.
• Offers online consultations for global HIPEC patient accessibility.
• Fluent in multiple languages, facilitating diverse patient communication.

• Dr. Phd Viola Fox specializes in Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
• Performs HIPEC by circulating heated chemotherapy in the abdominal cavity.
• Innovative HIPEC methods: real-time monitoring, pressurized intraperitoneal aerosol chemotherapy (PIPAC).
• International training in onco-surgery, with a focus on peritoneal carcinomatosis.
• Holds certifications in hematology, oncology, and genetic specialization.
• Member of German Society for Oncology (GDHO) and the American Association for Cancer Research.
• Offers remote consultations for HIPEC patients in multiple languages.

Dr. Raj is a highly experienced Surgical Oncologist with 19 years of experience and over 50,000 cancer surgeries performed. He is involved in numerous clinical trials and has many international and national publications to his credit. He specializes in Breast and Thoracic Surgical Oncology and serves as a professor for DNB Superspecialty Surgical Oncology and Breast Surgery at the Maharashtra University of Health Sciences. His belief is in "adding life to years" and improving the quality of life, not just adding years to life.